MK-0616 is smashing all competitors for the prevention and treatment of atherosclerosis.
Novartis
Posted inClinical Trials, Metabolism
Baxdrostat: New Treatment for Resistant Hypertension
A selective aldosterone synthase inhibitor for significantly lowering blood pressure.
Posted inAutoimmune Diseases, New Drugs, Regulatory
Sotyktu: Miracle Pill for Autoimmune Diseases
Deucravacitinib by Bristol-Myers Squibb can help with psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, and systemic lupus erythematosus.
Posted inAutoimmune Diseases, Clinical Trials, In the Pipeline, New Drugs, Regulatory
Alopecia Areata Treatment: What Future Holds
What new drugs for hair loss are being developed by the pharmaceutical industry?
Posted inAutoimmune Diseases, Clinical Trials, Neuroscience
Ublyxi: Highly Effective Drug for Multiple Sclerosis
Ublituximab is the third anti-CD20 therapy for multiple sclerosis and a worthy rival to Ocrevus and Kesimpta.
Posted inMetabolism, New Drugs, Regulatory
Camzyos: First Specific Drug to Treat Hypertrophic Cardiomyopathy
Mavacamten by Bristol-Myers Squibb is a new breath for all patients with obstructive hypertrophic cardiomyopathy.
Posted inAutoimmune Diseases, New Drugs, Rare/Orphan Diseases, Regulatory
Tepezza: First Drug for Thyroid Eye Disease
Teprotumumab by Horizon Therapeutics can really help with proptosis and diplopia in Graves’ disease and beyond.
